Andrew Hull, Director of InMed Pharmaceuticals INM, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/12/19.

AH

AH

Andrew Hull

Director

Company

InMed Pharmaceuticals INM

First filing

23/12/26

Trades

7 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/12/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
InMed PharmaceuticalsINM	Open-market buy	24/02/21	24/02/22	37,500 sh	$0.39	$14,625	+4947.2%